Addenda

On This Page:

• General Information
• Sunday, July 12
• Monday, July 13
• Tuesday, July 14
• Wednesday, July 15
• Thursday, July 16

General Information

New Exhibitors

• AD/PD 2027 - Booth 843
• CrossSense Ltd. - Booth 1139
• CURE-ND - Booth 1137
• Inoviv - Booth 1502
• Julius Clinical - Booth 827
• Kneu Health - Booth 633
• NIHR Research Delivery Network - Booth 218
• Proteome Sciences - Booth 1500
• SMarT Minds Dx - Booth 105
• Summit Clinical Research - Booth 1037
• Tosoo - Booth 841
• Transpharmation - Booth 845
• TrilliumBiO - Booth 847
• UK Dementia Research Institute - Booth 1041
• University of Nottingham - Booth 1236

Room Changes

• S8 to S9 entrance
• N10 to N11 A entrance
• N11 to N11 B entrance

Sunday, July 12

Updated Session Titles

• 8-8:45 a.m.
  • 1-02-DEV in ICC Auditorium
    Developing Topics In Brain Signatures
  • 1-03-DEV in N11 B
    Developing Topics In Pre-Existing Medical Conditions And Reproductive Factors
  • 1-06-DEV in George V 3/4
    Developing Topics In Genetics And Genomics
  • 1-07-DEV in George V 1/2
    Developing Topics In ADRD Staging
• 9-10:30 a.m.
  • 1-12-DEV in ICC Auditorium
    Borrowing Wisely; Stroke Learnings Applied To ARIA (A Joint Session Organized By Alzheimer’s Association & American Stroke Association)
• 2-3:30 p.m.
  • 1-23-DEV in N11 B
    Developing Topics In Amyloid Targeting Therapies: Global Perspectives From Trials To Real World Evidence
• 4:15-5:45 p.m.
  • 1-32-DEV in ICC auditorium
    Lecanemab Subcutaneous Formulation In Early Alzheimer’s Disease: Emerging Clinical Evidence And Practical Use Consideration
  • 1-33-DEV in N11 B
    Fluid Biomarkers Of Co-Pathology In Alzheimer’s Disease
  • 1-37-CTB-B in GeorgeV 1/2
    Mini Clinicopathological Correlation (CPC) Conference
  • 1-38-DEV in Victoria 1/4
    AI And Informatics: Advances In Alzheimer’s Disease Multimodal Analytics And Diagnosis

Updated Session Description

• Closing the Diagnostic Gap: Utilizing pTau217 for Scalable Alzheimer’s Disease Diagnosis, sponsored by Roche

Monday, July 13

Updated Session Title

• 8-8:45 a.m.
  • 2-02-DEV in ICC Auditorium
    Developing Topics In Genetic Factors In Neurodegenerative Disease
  • 2-03-DEV in N11 B
    Developing Topics In Modifiable Risk Factors
  • 2-06-DEV in George V 3/4
    Developing Topics In Amyloid Targeting Therapies And Real World Outcomes
  • 2-07-DEV in George V 1/2
    Developing Topics In Global Factors
• 9-10:30 a.m.
  • 2-13-DEV in N11 B
    Alzheimer’s Disease And Related Dementias Clinical Trials Early Career Investigator Oral Abstracts Session
• 2-3:30 p.m.
  • 2-23-DEV in N 11
    Addressing Gender/Sex Differences In The Wicked Problem Of Dementia With The Population Neuroscience-Dementia Syndemics Framework
• 4:15-5:45 p.m.
  • 2-32-DEV in ICC Auditorium
    Advances In Preclinical Humanized Therapeutic Development For Dementia
  • 2-33-DEV in N11 B
    Developing Topics In Lifestyle Interventions

Updated Times and/or Locations

• ISTAART Member Reception, sponsored by Wiley’s Advanced Portfolio — Monday, July 13 from 6:15-8 p.m, at the InterContinental London-The O2 (Arora Ballroom).
• Alliance Of Women Alzheimer’s Researchers (AWARE) PIA 12th Annual Mentoring Breakfast — Monday, July 13 from 6:30-7:30 a.m., at the Crowne Plaza London Docklands (Docklands Suite).

Updated Session Description

• From Evidence to Life: A Clinical and Human Perspective in Early Alzheimer’s Disease, sponsored by Lilly

Tuesday, July 14

Cancellation

• 12:30-1:45 p.m.
  • ISTAART Skills Workshop in Connaught 3
    Science Communication: Do's, Don'ts, Let's!

Updated Session Titles

• 8-8:45 a.m.
  • 3-03-DEV in N11 B
    Developing Topics In Factors Affecting Fluid Biomarkers
  • 3-04-DEV in S11
    Developing Topics In Pathological Changes Resulting From Amyloid Targeting Treatment In Alzheimer’s Disease
  • 3-06-DEV in George V 3/4
    Developing Topics In Biomarkers And Novel Tools For Dementia Risk And Care
  • 3-07-DEV in George V 1/2
    Developing Topics In Prevention, Diagnosis And Prognosis
• 9-10:30 a.m.
  • 3-13-DEV in N11 B
    Immune-Based Therapy For Neurodegenerative Diseases
• 2-3:30 p.m.
  • 3-22-DEV in ICC Auditorium
    Developing Topics In Phase 2 Clinical Trials
  • 3-23-DEV in N 11
    The MindCare Primary Care Screening Model: Design, Implementation, Initial Results And Public Health Implications For Dementia Risk Reduction
• 4:15-5:45 p.m.
  • 3-33-DEV-A in room N11 B
    Lecanemab Three Years Post-Approval: A Comprehensive Multicenter, Real-World, Retrospective Study (LEADER) in Diverse US Clinical Settings
  • 3-37-DEV-C in George V 1/2
    Real-World Validation of Alzheimer's Disease Blood Tests from Community to Primary Care Settings: Updates on SEABIRD and SUNBIRD

Updated Time and/or Locations

• Diversity and Disparities PIA 8th Annual Mentoring Breakfast — Tuesday, July 14 from 6:30-7:30 a.m., at the Crowne Plaza London Docklands (Docklands Suite).
• Alliance of Women Alzheimer's Researchers (AWARE) PIA: Panel and Networking Event at AAIC 2026 — Tuesday, July 14 from 7-8:15 p.m., at the Crowne Plaza London Docklands (Docklands Suite).

Updated Session Description

• Early Intervention in Alzheimer’s Disease: Building the Evidence from Pathology to Practice, sponsored by Eisai and Biogen

Wednesday, July 15

Updated Session Titles

• 8-8:45 a.m.
  • 4-02-DEV in ICC Auditorium
    Developing Topics In Phase 1 And Phase 2 Clinical Trials
  • 4-03-DEV in N11 B
    Developing Topics In Disease Continuum And Staging
  • 4-04-DEV in S11
    Developing Topics In ADRD Diagnostics
  • 4-07-DEV in George V 1/2
    Developing Topics In Preclinical Models
  • 4-08-DEV in Victoria 1/4
    Developing Topics In Vascular And CSF Changes
• 9-10:30 a.m.
  • 4-12-DEV in ICC Auditorium
    Donanemab in Early Symptomatic Alzheimer’s Disease: Evidence to Address Clinical Questions
• 2-3:30 p.m.
  • 4-23-DEV in N11 B
    Beyond GWAS: Rare And Complex Genomic Variation In Alzheimer’s Disease Across Diverse Populations
• 4:15-5:45 p.m.
  • 4-33-EC in room N11 B
    Emerging Concepts in Basic Science: Panel Discussion

Thursday, July 16

Location Changes

• 10 a.m.-1:30 p.m.
  • 5-1-AC in N11 B entrance
    AAIC For All: Clinicians track
  • 5-2-AC in S9 Entrance
    AAIC For All: Community track